Childhood-onset systemic lupus erythematosus presenting with growth retardation and delayed puberty: a case report - Report - MDSpire

Childhood-onset systemic lupus erythematosus presenting with growth retardation and delayed puberty: a case report

  • By

  • Yumo Liu

  • Xinyu Li

  • Zhengnan Gao

  • Xuhan Liu

  • May 25, 2026

  • 0 min

Share

Clinical Report: Systemic Lupus Erythematosus with Childhood Onset

Overview

This report presents a case of a 12-year-old girl with childhood-onset systemic lupus erythematosus (cSLE) who exhibited growth delays and delayed puberty as initial symptoms. Despite treatment, growth and pubertal progression remained impaired, emphasizing the need for early recognition and management of cSLE in adolescents.

Background

Childhood-onset systemic lupus erythematosus (cSLE) is a significant autoimmune condition that can lead to severe morbidity and complications, particularly in pediatric populations. The atypical presentation of growth retardation and delayed puberty can complicate diagnosis, leading to delays in appropriate treatment. Understanding these manifestations is crucial for timely intervention and improved long-term outcomes in affected children.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • cSLE accounts for 15%-20% of all SLE cases, with a peak onset age of 10-13 years.
  • Initial symptoms may include growth retardation and delayed puberty, complicating diagnosis.
  • In the reported case, the patient showed significant growth deceleration and absence of pubertal development.
  • Immunosuppressive therapy improved systemic manifestations, but growth and puberty remained impaired.
  • Early recognition of cSLE is essential in adolescents with unexplained growth or pubertal delays.

Clinical Implications

Healthcare providers should consider cSLE in differential diagnoses for adolescents presenting with growth delays or delayed puberty, especially when accompanied by signs of renal involvement or immunological abnormalities. Multidisciplinary management is crucial to address both the autoimmune disease and its impact on growth and development.

Conclusion

This case underscores the importance of recognizing cSLE as a potential cause of growth and pubertal delays in children. Early diagnosis and comprehensive management can significantly influence long-term health outcomes.

Related Resources & Content

  1. Chimeric Antigen Receptor T Cell Therapy for Pediatric Systemic Lupus Erythematosus, Clinical Rheumatology, 2025 -- https://link.springer.com/article/10.1007/s10067-025-07550-5
  2. Clinical Characteristics, Autoantibody Profiles, and Therapeutic Outcomes of Juvenile Systemic Sclerosis: An 11-Year Single-Center Experience from China, Frontiers in Immunology, 2026 -- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1818010/full
  3. Management and Long-Term Outcomes in Children with Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS): A Review of Case Studies, Clinical Rheumatology, 2025 -- https://link.springer.com/article/10.1007/s10067-025-07509-6
  4. Deteriorating Growth Patterns in Prepubertal Children Diagnosed with APECED, The Journal of Clinical Endocrinology & Metabolism -- https://academic.oup.com/jcem/article/110/2/e257/7641485
  5. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus - PubMed -- https://pubmed.ncbi.nlm.nih.gov/41182321/?utm_source=openai
  6. Lupus Nephritis (LN) – KDIGO -- https://kdigo.org/guidelines/lupus-nephritis/?utm_source=openai
  7. Revisiting Childhood-Onset Systemic Lupus Erythematosus - PMC -- https://pmc.ncbi.nlm.nih.gov/articles/PMC11332533/?utm_source=openai
  8. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus - PubMed
  9. Lupus Nephritis (LN) – KDIGO
  10. Revisiting Childhood-Onset Systemic Lupus Erythematosus - PMC

Original Source(s)

Related Content